InternationalUSRemember you can easily switch between MIP US and MIP International at any time

South Africa considers pharma patent changes


After several years of relative calm, pharmaceutical patents are in the spotlight again in South Africa, with a new Draft IP Policy launched. Russell Bagnall and Dario Tanziani explain why it has been introduced, and discuss the changes proposed

Access to medicines, and the role that the patent system plays in preventing such access, became the subject of debate several years ago in South Africa. In the early 2000s, and at a time when the HIV-AIDS pandemic reached very...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog


null

null null null

null null null

Mid Year 2018

PTAB practice in a post-SAS world

The big questions remaining after the Supreme Court’s SAS ruling include how institution rates will change, how strategy at the Board should evolve, and how district courts and the Federal Circuit will react. Michael Loney investigates



Most read articles

Supplements